This two-day conference targets radiation oncologists, medical oncologists, nuclear medicine physicians, urologists, radiologists, and advanced practice providers (APPs) involved in managing prostate cancer patients.  We will review PSMA PET imaging, including how to interpret and report the imaging and review the current data supporting its use and impacts on patient care.  Subsequently, we will focus on PSMA-targeted radioligand therapy to define patient selection and management of treatment.  The roles of combination therapy, the impact of future trials, and dosimetry will be presented.  Tumor boards will be used to highlight the role of PSMA imaging and therapy in prostate cancer patients.  Speakers will include nuclear medicine physicians, medical oncologists, radiation oncologists, urologists, APPs from UCLA and UCSF, and additional thought leaders.

When and Where

The conference will offer both in-person and virtual attendance.

Cost

Registration will close on January 17 @ 12:00 PM PST. Pre-registration is encouraged to ensure space in the conference.